1.5 T 磁共振直线加速器上定量成像的可行性与准确性
本研究在四家机构的四台 1.5 T 磁共振直线加速器系统上,用体模评估 T1、T2 弛豫时间、表观扩散系数(ADC)图和动态对比增强(DCE)成像的准确性、重复性与再现性,并首次在前列腺癌患者中展示定量 MRI 的可行性。结果显示定量 MRI 在该系统上可行、准确且可重复,有望用于治疗反应监测和基于每日定量 MRI 的治疗计划调整。
要点
- 四台 1.5 T 磁共振直线加速器系统上,T1 中位准确性为 2.7% 至 14.3%,T2 为 10.4% 至 14.1%,ADC 为 1.9% 至 2.7%。
- DCE 在钆浓度 0.5 mM 时准确性为 12.8% 至 35.8%,浓度更高时准确性下降。
- T1、T2、ADC 的长期重复性分别为 1.8%、1.4%、1.7%,DCE 为 17.9%;再现性分别为 11.2%、2.9%、2.2%、18.4%。
核心结论
- 结果表明,Unity 磁共振直线加速器上的定量 MRI 可行、准确且可重复,有望用于治疗反应监测和基于每日定量 MRI 的治疗计划调整。
研究设计与样本
- 研究纳入四家机构的四台 1.5 T 磁共振直线加速器系统,在体模上获取 T1、T2 弛豫时间、ADC 图和 DCE 图像,采用 Bland-Altman 统计方法确定准确性、重复性和再现性。
- 研究还在该系统的前列腺癌患者中首次展示定量 MRI 的可行性。
主要发现
- 四台系统上 T1 的中位准确性范围为 2.7% 至 14.3%,T2 为 10.4% 至 14.1%,ADC 为 1.9% 至 2.7%。
- DCE 图像在钆浓度 0.5 mM 时准确性为 12.8% 至 35.8%,浓度更高时准确性变差。
- T1 的中位短期重复性范围为 0.6% 至 5.1%,T2 为 0.4% 至 1.2%,ADC 为 1.3% 至 2.2%。
- DCE 采集的信号强度变异系数为 0.1% 至 0.6%。
- 长期重复性 T1 为 1.8%、T2 为 1.4%、ADC 为 1.7%、DCE 为 17.9%;再现性 T1 为 11.2%、T2 为 2.9%、ADC 为 2.2%、DCE 为 18.4%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Systems for magnetic resonance (MR-) guided radiotherapy enable daily MR imaging of cancer patients during treatment, which is of interest for treatment response monitoring and biomarker discovery using quantitative MRI (qMRI). Here, the performance of a 1.5 T MR-linac regarding qMRI was assessed on phantoms. Additionally, we show the feasibility of qMRI in a prostate cancer patient on this system for the first time. MATERIALS AND METHODS: Four 1.5 T MR-linac systems from four institutes were included in this study. T1 and T2 relaxation times, and apparent diffusion coefficient (ADC) maps, as well as dynamic contrast enhanced (DCE) images were acquired. Bland-Altman statistics were used, and accuracy, repeatability, and reproducibility were determined. RESULTS: Median accuracy for T1 ranged over the four systems from 2.7 to 14.3%, for T2 from 10.4 to 14.1%, and for ADC from 1.9 to 2.7%. For DCE images, the accuracy ranged from 12.8 to 35.8% for a gadolinium concentration of 0.5 mM and deteriorated for higher concentrations. Median short-term repeatability for T1 ranged from 0.6 to 5.1%, for T2 from 0.4 to 1.2%, and for ADC from 1.3 to 2.2%. DCE acquisitions showed a coefficient of variation of 0.1-0.6% in the signal intensity. Long-term repeatability was 1.8% for T1, 1.4% for T2, 1.7% for ADC, and 17.9% for DCE. Reproducibility was 11.2% for T1, 2.9% for T2, 2.2% for ADC, and 18.4% for DCE. CONCLUSION: These results indicate that qMRI on the Unity MR-linac is feasible, accurate, and repeatable which is promising for treatment response monitoring and treatment plan adaptation based on daily qMRI.
引用
- Kooreman ES, van Houdt PJ, Nowee ME, et al. Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator. Radiother Oncol. 2019. PMID: 30935572. doi:10.1016/j.radonc.2019.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。